These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 38667527)

  • 1. The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease.
    Scarlata GGM; Colaci C; Scarcella M; Dallio M; Federico A; Boccuto L; Abenavoli L
    Diseases; 2024 Mar; 12(4):. PubMed ID: 38667527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease.
    Fuenzalida C; Dufeu MS; Poniachik J; Roblero JP; Valenzuela-Pérez L; Beltrán CJ
    Front Pharmacol; 2021; 12():729950. PubMed ID: 34630107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcoholic liver disease: A current molecular and clinical perspective.
    Ohashi K; Pimienta M; Seki E
    Liver Res; 2018 Dec; 2(4):161-172. PubMed ID: 31214376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcoholic Hepatitis: A Review.
    Hosseini N; Shor J; Szabo G
    Alcohol Alcohol; 2019 Jul; 54(4):408-416. PubMed ID: 31219169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?
    Kim MS; Ong M; Qu X
    World J Gastroenterol; 2016 Jan; 22(1):8-23. PubMed ID: 26755857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver disease.
    Martinez-Castillo M; Altamirano-Mendoza I; Sánchez-Valle S; García-Islas L; Sánchez-Barragán M; Hernández-Santillán M; Hernández-Barragán A; Pérez-Hernández JL; Higuera-de la Tijera F; Gutierrez-Reyes G
    Rev Gastroenterol Mex (Engl Ed); 2023; 88(2):136-154. PubMed ID: 36973122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
    Way GW; Jackson KG; Muscu SR; Zhou H
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrogenesis in alcoholic liver disease.
    Fujii H; Kawada N
    World J Gastroenterol; 2014 Jul; 20(25):8048-54. PubMed ID: 25009376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of inflammatory cytokines in alcoholic liver disease.
    Kawaratani H; Tsujimoto T; Douhara A; Takaya H; Moriya K; Namisaki T; Noguchi R; Yoshiji H; Fujimoto M; Fukui H
    Mediators Inflamm; 2013; 2013():495156. PubMed ID: 24385684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease.
    Robinson KE; Shah VH
    Transl Gastroenterol Hepatol; 2020; 5():49. PubMed ID: 33073044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol and the mechanisms of liver disease.
    Chen M; Zhong W; Xu W
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1233-1240. PubMed ID: 37423758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
    Hong M; Han DH; Hong J; Kim DJ; Suk KT
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
    Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in alcoholic liver disease.
    An L; Wang X; Cederbaum AI
    Arch Toxicol; 2012 Sep; 86(9):1337-48. PubMed ID: 22367091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcoholic liver disease: mechanisms of injury and targeted treatment.
    Louvet A; Mathurin P
    Nat Rev Gastroenterol Hepatol; 2015 Apr; 12(4):231-42. PubMed ID: 25782093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcoholic liver disease: Current insights into cellular mechanisms.
    Petagine L; Zariwala MG; Patel VB
    World J Biol Chem; 2021 Sep; 12(5):87-103. PubMed ID: 34630912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease.
    Sangineto M; Grabherr F; Adolph TE; Grander C; Reider S; Jaschke N; Mayr L; Schwärzler J; Dallio M; Moschen AR; Moschetta A; Sabbà C; Tilg H
    Liver Int; 2020 Jul; 40(7):1610-1619. PubMed ID: 32306456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota.
    Jung JH; Kim SE; Suk KT; Kim DJ
    Front Med (Lausanne); 2022; 9():913842. PubMed ID: 35935787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease.
    Dukić M; Radonjić T; Jovanović I; Zdravković M; Todorović Z; Kraišnik N; Aranđelović B; Mandić O; Popadić V; Nikolić N; Klašnja S; Manojlović A; Divac A; Gačić J; Brajković M; Oprić S; Popović M; Branković M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.